Sequencing medical therapy in prostate cancer: not as easy as 1-2-3
Kessler, E.R.; Flaig, T.W.
Oncology 27(11): 1158-1160
2013
ISSN/ISBN: 0890-9091 PMID: 24575544 Document Number: 669697
Document emailed within 1 workday
Related Documents
Ojeda, A.V.; Ledo, M.ía.J.é; Alvarez-Ossorio, J.é L.ís. 2018: Sequencing and combination of agents in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 711-720Nelson, J.E.; Krawetz, S.A. 1994: Easy-read DNA sequencing gels Biotechniques 17(3): 416; 418
Gold, P. 1992: Use of a novel agarose gel-digesting enzyme for easy and rapid purification of PCR-amplified DNA for sequencing Biotechniques 13(1): 132-134
Schäfer, U.; Micke, O.; Hampel, G.; Brandt, B.; Bovenschulte, A.; Semjonow, A.; Willich, N. 1997: The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer Anticancer Research 17(4b): 2983-2986
Leewansangtong, S.; Soontrapa, S. 2003: The pattern of prostate-specific antigen responses following hormonal therapy in Thai men with bone metastatic prostate cancer Journal of the Medical Association of Thailand 86(9): 809-815
Heumann, T.R.; Diaz, R.; Liu, Y.; Hanley, K.; Bang, S.; Horowitz, I.R.; Khanna, N.; Shelton, J.W. 2017: Clinical outcomes and the role of adjuvant therapy sequencing in Type Ii uterine cancer following definitive surgical treatment European Journal of Gynaecological Oncology 38(3): 404-412
Tu, S.-M.; Lin, S.-H.; Podoloff, D.A.; Logothetis, C.J. 2010: Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer Clinical Advances in Hematology and Oncology: H&o 8(5): 341-351
Mayer, F.J.; Crawford, E.D. 1994: The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy Urologic Clinics of North America 21(4): 707-715
Bercovici, S.; Georgescu, M.; Ioachim, A. 1971: Medical aspects of cancer of the prostate Medicina Interna 23(11): 1377-1387
Reddy, S.V.; Gupta, S.K. 2012: Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence? Singapore Medical Journal 53(3): E52-E54
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Watanabe, A.; Taniguchi, M. 2005: A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 65-67
Kawai, K. 2007: Surgical and medical treatment for localized prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(7): 1002-1005
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Gay, H.A.; Michalski, J.M. 2018: Radiation Therapy for Prostate Cancer Missouri Medicine 115(2): 146-150
Nasu, Y.; Abarzua, F.; Kumon, H. 2005: Prostate cancer gene therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 12): 544-547